leisure time -WSS

leisure time

author：explore 2025-09-07 17:23:46 - browse：366

STAT Q&A — Paul Matteis (right), in 2017 with then-colleagues Seamus Fernandez (far left) Geoffrey Porges. Alex Hogan/STAT

NEW YORK — Is biotech having a renaissance in neuroscience? Can we solve the placebo effect? And what’s going to happen next year?

Paul Matteis, co-head of biotech research at Stifel, sat down with STAT at the firm’s annual health care conference here to field those questions and opine on how management teams can walk the delicate balance between hype and sandbagging. This transcript has been edited for length and clarity.

One thing I’ve been hearing lately is that biotech has entered a sort of renaissance in neuroscience. Do you agree with that?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： ACA's risk program benefits Blue Cross Blue Shield insurers

WSS

Chris Christie meets with Zelenskyy during Ukraine trip

Recent heat wave in the Mediterranean caused by climate change: Study

The cancer stories no one wants to hear

Eisai exec who led development of Alzheimer’s drug to retire

Biden declares emergency in flood

The cancer stories no one wants to hear

Wikipedia

leisure time

knowledge

Cancer drug shortages should be causing more outrage

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Guidelines to prevent youth baseball injuries need more muscle

ACA's risk program benefits Blue Cross Blue Shield insurers

Guidelines to prevent youth baseball injuries need more muscle

How I helped Pfizer think through the ethics of Viagra

Dobbs anniversary: the lost opportunity of abortion as health care

Chris Christie meets with Zelenskyy during Ukraine trip

In age of alternative facts, a scholarly course on calling out crap

H.R. 3 is the wrong path to lower drug costs

entertainment

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Chris Christie meets with Zelenskyy during Ukraine trip

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

White House announces new plan to address the growing threat of xylazine in overdose crisis

Swim instructor mom warns parents not to buy blue swimsuits for kids

focus

knowledge

focus

Wikipedia